APFIVE Insulin Release Inhibition Experiment
A researcher administers a substance designed to inhibit insulin release to a subject with low blood glucose levels. The expected decrease in insulin release is not observed, even though the substance’s efficacy was validated in prior studies. Which of the following best explains this result?
A
The dose of the substance was too low to have a noticeable effect.
B
The administered substance was degraded before it could take effect.
C
The cells responsible for insulin release might not be sensitive to the administered substance.
D
The substance was administered at the wrong time of day.
Question Leaderboard
| Rank | |||||
|---|---|---|---|---|---|
| #1 | borys.w | 2 | 2 | 1m 26s | 114 |
| #2 | gjm200294 | 1 | 1 | 0m 00s | 100 |
| #3 | lilliaperry | 1 | 1 | 0m 00s | 100 |
| #4 | tanvithandri | 1 | 1 | 0m 00s | 100 |
| #5 | eyas.alsaid | 1 | 1 | 0m 00s | 100 |
| #6 | angelarosechavez | 1 | 1 | 0m 35s | 65 |
| #7 | jdvillalta865 | 1 | 1 | 0m 41s | 59 |
| #8 | Talammdalal | 0 | 1 | 0m 00s | -10 |
Items per page:
10
1 – 8 of 8